At admission for DKA, the patient received standard treatment, including continuous intravenous insulin infusion and isotonic saline, with close monitoring of electrolyte levels and acid-base balance. In light of her SARS-CoV-2 infection and high-risk profile, including T1DM, advanced age, and recent signs of functional decline, oral molnupiravir was administered at 800 mg twice daily for five days. Here, INS is linked to type 1 diabetes mellitus.